PHARMACEUTICAL IMPURITY PROFILING - METOCLOPRAMIDE IMPURITIES

Evaluation of the Importance of Accurate Mass, Mass Resolution and Dynamic Range for Impurity Profiling Applications with Multistage Mass Spectrometry David A. Weil*, Zoltan Timar and Michael Zumwalt Agilent Technologies Schaumburg, IL/ Boulder, CO [email protected] Impurity Profiling 2008 Page 1…

PO-CON1878E Simplified approach for structural elucidation and quantitation for pharmaceutical API and related impurities ASMS 2019 TP 746 Purushottam Sutar, Anant Lohar, Ashutosh Shelar, Deepti Bhandarkar, Bhaumik Trivedi, Navin Devadiga, Rashi Kochhar, Shailendra Rane, Shailesh Damale, Ajit Datar, Pratap Rasam…

UPC 2 Method Development for Achiral Impurity Analysis Michael D. Jones, Andrew Aubin, Paula Hong, and Warren Potts Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E N E F I T…

Application Note Pharma & Biopharma Improved Sensitivity for Low‑Level Impurity Detection with the Agilent 1260 Infinity II SFC System Featuring an Agilent 1260 Infinity II Variable Wavelength Detector Metoclopramide mAU 25 Impurity D Impurity C 20 15 10 Impurity B…